The future of glioblastoma therapy - a podcast by BMJ Group

Despite current standard care for glioblastoma being aggressive, mean survival is around 14 months. Clark Chen (director of Clinical Neuro-oncology, Beth Israel Deaconess Medical Center, Boston) argues we need a better understanding of the therapeutic concepts that have evolved over the past three decades to develop treatment, and in a JNNP article this month he lays out seven of these key ideas. Peter Warnke (JNNP associate editor) discusses them with him.

See also:

Key concepts in glioblastoma therapy http://tinyurl.com/ao8g8m3

Further episodes of JNNP podcast

Further podcasts by BMJ Group

Website of BMJ Group